218 related articles for article (PubMed ID: 33921698)
1. MRCKα Is Dispensable for Breast Cancer Development in the MMTV-PyMT Model.
Kwa MQ; Brandao R; Phung TH; Ge J; Scieri G; Brakebusch C
Cells; 2021 Apr; 10(4):. PubMed ID: 33921698
[TBL] [Abstract][Full Text] [Related]
2. Deletion of
Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
[TBL] [Abstract][Full Text] [Related]
3. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
4. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
6. Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.
Fang WB; Jokar I; Chytil A; Moses HL; Abel T; Cheng N
Clin Exp Metastasis; 2011 Apr; 28(4):351-66. PubMed ID: 21374085
[TBL] [Abstract][Full Text] [Related]
7. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
[TBL] [Abstract][Full Text] [Related]
8. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
9. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.
Boyle ST; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945
[TBL] [Abstract][Full Text] [Related]
10. Knockout model reveals the role of Nischarin in mammary gland development, breast tumorigenesis and response to metformin treatment.
Dong S; Ruiz-Calderon B; Rathinam R; Eastlack S; Maziveyi M; Alahari SK
Int J Cancer; 2020 May; 146(9):2576-2587. PubMed ID: 31525254
[TBL] [Abstract][Full Text] [Related]
11. Co-crystal structures of inhibitors with MRCKβ, a key regulator of tumor cell invasion.
Heikkila T; Wheatley E; Crighton D; Schroder E; Boakes A; Kaye SJ; Mezna M; Pang L; Rushbrooke M; Turnbull A; Olson MF
PLoS One; 2011; 6(9):e24825. PubMed ID: 21949762
[TBL] [Abstract][Full Text] [Related]
12. A novel small-molecule MRCK inhibitor blocks cancer cell invasion.
Unbekandt M; Croft DR; Crighton D; Mezna M; McArthur D; McConnell P; Schüttelkopf AW; Belshaw S; Pannifer A; Sime M; Bower J; Drysdale M; Olson MF
Cell Commun Signal; 2014 Oct; 12():54. PubMed ID: 25288205
[TBL] [Abstract][Full Text] [Related]
13. Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Sundaram S; Yan L
J Nutr Biochem; 2020 Mar; 77():108313. PubMed ID: 31837540
[TBL] [Abstract][Full Text] [Related]
14. MMTV-PyMT and Derived Met-1 Mouse Mammary Tumor Cells as Models for Studying the Role of the Androgen Receptor in Triple-Negative Breast Cancer Progression.
Christenson JL; Butterfield KT; Spoelstra NS; Norris JD; Josan JS; Pollock JA; McDonnell DP; Katzenellenbogen BS; Katzenellenbogen JA; Richer JK
Horm Cancer; 2017 Apr; 8(2):69-77. PubMed ID: 28194662
[TBL] [Abstract][Full Text] [Related]
15. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
16. The CDC42 effector protein MRCKβ autophosphorylates on Threonine 1108.
Unbekandt M; Lilla S; Zanivan S; Olson MF
Small GTPases; 2020 Nov; 11(6):451-460. PubMed ID: 30667325
[TBL] [Abstract][Full Text] [Related]
17. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models.
Du Z; Podsypanina K; Huang S; McGrath A; Toneff MJ; Bogoslovskaia E; Zhang X; Moraes RC; Fluck M; Allred DC; Lewis MT; Varmus HE; Li Y
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17396-401. PubMed ID: 17090666
[TBL] [Abstract][Full Text] [Related]
18. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
19. In vivo fluorescence imaging reveals the promotion of mammary tumorigenesis by mesenchymal stromal cells.
Ke CC; Liu RS; Suetsugu A; Kimura H; Ho JH; Lee OK; Hoffman RM
PLoS One; 2013; 8(7):e69658. PubMed ID: 23936067
[TBL] [Abstract][Full Text] [Related]
20. Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development.
Oloumi A; Maidan M; Lock FE; Tearle H; McKinney S; Muller WJ; Aparicio SA; Dedhar S
Breast Cancer Res; 2010; 12(3):R38. PubMed ID: 20565980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
